Free Trial

Aerovate Therapeutics (AVTE) SEC Filings & 10K Form

Aerovate Therapeutics logo
$2.53 0.00 (0.00%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$2.53 +0.00 (+0.16%)
As of 03/28/2025 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Aerovate Therapeutics SEC Filings

DateFilerForm TypeView
03/27/2025
6:30 AM
Aerovate Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2025
3:54 PM
Aerovate Therapeutics (Subject)
Form 425
03/25/2025
11:15 PM
Aerovate Therapeutics (Filer)
Form EFFECT
03/25/2025
3:25 PM
Aerovate Therapeutics (Filer)
Form 424B3
03/24/2025
9:45 AM
Aerovate Therapeutics (Filer)
Form S-4/A
03/14/2025
4:16 PM
Aerovate Therapeutics (Filer)
Form S-4/A
03/03/2025
3:45 PM
Aerovate Therapeutics (Subject)
Form 425
02/24/2025
8:57 AM
Aerovate Therapeutics (Filer)
Form S-4/A
01/24/2025
3:17 PM
Aerovate Therapeutics (Subject)
Form 425
01/22/2025
7:45 AM
Aerovate Therapeutics (Filer)
Form S-4/A
01/13/2025
4:24 PM
Aerovate Therapeutics (Subject)
Form 425
12/03/2024
5:27 AM
Aerovate Therapeutics (Filer)
Form S-4
Registration statement under Securities Act of 1933  
11/18/2024
4:29 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:55 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:55 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
3:57 PM
Aerovate Therapeutics (Subject)
Form 425
10/31/2024
8:27 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
8:29 AM
Aerovate Therapeutics (Subject)
Form 425
10/17/2024
3:59 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
4:04 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
3:31 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
7:00 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2024
5:00 PM
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
06/20/2024
4:56 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:35 AM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
3:44 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
4:00 PM
Aerovate Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/07/2024
7:29 PM
Aerovate Therapeutics (Issuer)
Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dorval Allison (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dable Habib J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Iwicki Mark T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Katabi Maha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Resnick Joshua (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Santel Donald J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:10 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

05/17/2024
6:10 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:57 PM
Aerovate Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2024
3:39 PM
Aerovate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2024
4:59 PM
Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
3:16 PM
Aerovate Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13D/A
04/26/2024
4:23 PM
Aerovate Therapeutics (Filer)
Form ARS
04/26/2024
6:18 AM
Aerovate Therapeutics (Filer)
Form DEF 14A
04/26/2024
6:19 AM
Aerovate Therapeutics (Filer)
Form DEFA14A
04/19/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:35 PM
Aerovate Therapeutics (Subject)
Dake Benjamin T (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2024
3:35 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:25 PM
Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/12/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
5:00 PM
Aerovate Therapeutics (Issuer)
GRAYZEL DAVID S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2024
5:42 PM
Aerovate Therapeutics (Subject)
Atlas Venture Associates XII, L.P. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Eldridge George A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Verwijs Marinus (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
5:00 PM
Aerovate Therapeutics (Issuer)
NOYES TIMOTHY P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
6:18 PM
Aerovate Therapeutics (Subject)
Verwijs Marinus (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
6:24 PM
Aerovate Therapeutics (Subject)
NOYES TIMOTHY P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Gillies Hunter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:00 PM
Aerovate Therapeutics (Issuer)
Dake Benjamin T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
5:31 PM
Aerovate Therapeutics (Subject)
Gillies Hunter (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:AVTE) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners